Ellomay Capital (ELLO) CFO reports 73,500-share stock option holdings

Rhea-AI Filing Summary

Ellomay Capital Ltd. Chief Financial Officer Rubenbach Kalia filed an initial ownership report showing holdings of stock options over Ordinary Shares. The filing lists two option grants covering a combined 73,500 underlying Ordinary Shares at exercise prices of 29.3600 and 27.1400 per share.

One grant for 9,000 underlying shares, granted on November 30, 2021, is fully vested and expires on November 30, 2031. A second grant for 64,500 underlying shares, granted on January 12, 2026, will vest in three tranches through January 12, 2029 and expires on January 11, 2036.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Rubenbach Kalia

Role Chief Financial Officer

Type	Security	Shares	Price	Value
holding	Stock Option (right to buy)	--	--	--
holding	Stock Option (right to buy)	--	--	--

Holdings After Transaction: Stock Option (right to buy) — 9,000 shares (Direct)

Footnotes (1)

1. Stock options were granted on November 30, 2021 and are fully vested. Stock options were granted on January 12, 2026. 17,737 of the options will vest on January 12, 2027, 23,649 of the options will vest on January 12, 2028 and 23,114 of the options will vest on January 12, 2029.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Rubenbach Kalia

(Last) (First) (Middle)

18 ROTHSCHILD BLVD

(Street)

TEL AVIV 6688121

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Ellomay Capital Ltd. [ ELLO ]

3a. Foreign Trading Symbol
[ELLO]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	(1)	11/30/2031	Ordinary Shares	9,000	$29.36	D
Stock Option (right to buy)	(2)	01/11/2036	Ordinary Shares	64,500	$27.14	D

Explanation of Responses:

1. Stock options were granted on November 30, 2021 and are fully vested.

2. Stock options were granted on January 12, 2026. 17,737 of the options will vest on January 12, 2027, 23,649 of the options will vest on January 12, 2028 and 23,114 of the options will vest on January 12, 2029.

	/s/ Kalia Rubenbach	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Rubenbach Kalia report owning in Ellomay Capital (ELLO) on this Form 3?

Rubenbach Kalia reports holding stock options over Ellomay Capital Ordinary Shares. The filing lists two option grants with a combined 73,500 underlying shares, representing his derivative equity position as Chief Financial Officer at the time of this initial ownership report.

How many Ellomay Capital shares are covered by Rubenbach Kalia’s stock options?

The options cover 73,500 underlying Ordinary Shares. One grant relates to 9,000 shares and another to 64,500 shares. These figures reflect the total number of Ellomay Capital Ordinary Shares potentially issuable under Kalia’s reported stock option awards.

What are the exercise prices of Rubenbach Kalia’s Ellomay Capital stock options?

The reported exercise prices are 29.3600 and 27.1400 per share. Each price applies to a separate stock option grant over Ellomay Capital Ordinary Shares, defining the cost per share if Kalia exercises these options in the future.

When do Rubenbach Kalia’s Ellomay Capital stock options expire?

The options have two different expiration dates. The 9,000-share grant expires on November 30, 2031. The 64,500-share grant expires on January 11, 2036. These dates mark the final days on which each option grant can be exercised.

What is the vesting schedule for Rubenbach Kalia’s Ellomay Capital options granted in 2026?

The 2026 grant vests in three annual tranches. Of the 64,500 options, 17,737 vest on January 12, 2027, 23,649 vest on January 12, 2028, and 23,114 vest on January 12, 2029, creating a staggered vesting profile.

Are any of Rubenbach Kalia’s Ellomay Capital stock options already fully vested?

Yes, one option grant is fully vested. The filing notes that stock options granted on November 30, 2021, covering 9,000 underlying Ordinary Shares, are fully vested, meaning they are currently exercisable subject to their stated expiration date in 2031.